
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
LC49A4 (solute carrier family 49 member 4) is listed under the supplied gene name, but the annotation does not provide additional functional information. Its specific molecular activities, biological processes, and cellular localization therefore cannot be described reliably from the available data.
COS-1 is a simian cell line derived from CV-1 cells transformed with an origin-defective mutant of simian virus 40 (SV40) encoding wild-type large T antigen. The cells support replication and propagation of recombinant SV40 viruses and are widely used as a host system for molecular biology studies, including recombinant protein expression and viral vector research.
Each knockout cell line is validated by STR authentication, sterility testing (bacteria/fungi), and mycoplasma screening. Genotype is confirmed by two rounds of PCR and Sanger sequencing. Only clones that pass all QC criteria are released, ensuring reliable identity and performance for downstream applications.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: E4
Reference Transcript: SLC12A9-201
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use


Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?